Showing results (1491-1500 of 2,361) with videos related to
Sort By:
Pageof 237
Clinical Neuropharmacology|September 19, 2013
Safety of perioperative treatment with intravenous amantadine in patients with Parkinson diseaseAeyal Raz, Nirit Lev, Sharon Orbach-Zinger, et al.Clinical Neuropharmacology|June 21, 2013
Neuroleptic malignant syndrome induced by lamotrigineMasamichi Ishioka, Norio Yasui-Furukori, Kojiro Hashimoto, et al.Clinical Neuropharmacology|January 1, 1990
Factors affecting the clinical response to haloperidol therapy in schizophreniaS R Bareggi, M Mauri, R Cavallaro, et al.Clinical Neuropharmacology|January 1, 1985
Effective treatment of pure akinesia with L-threo-3,4-dihydroxyphenylserine (DOPS): report of a case, with pharmacological considerationsM Yamamoto, H Ujike, N OgawaClinical Neuropharmacology|June 1, 1997
A new clinical tool for gait evaluation in Parkinson's diseaseP Martínez-Martín, D García Urra, T del Ser Quijano, et al.Clinical Neuropharmacology|June 1, 1997
Automatic EMG-guided botulinum toxin treatment of spasticityJ Finsterer, I Fuchs, B MamoliClinical Neuropharmacology|June 1, 1997
Antinociceptive effects of the kappa-opioid receptor agonist RP 60180 compared with pentazocine in an experimental human pain modelJ Lötsch, W Ditterich, T Hummel, et al.Clinical Neuropharmacology|June 1, 1997
Long-term treatment with intermitent intranasal or subcutaneous apormorphine in patients with levodopa-related motor fluctuationsJ Esteban Muñoz, M J Martí, C Marín, et al.Clinical Neuropharmacology|October 1, 1993
Thyrotropin-releasing hormone produces different hemodynamic effects in vegetative and brain-dead patientsM Aibiki, Y Shirakawa, S Ogura, et al.Pageof 237